help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oftebro, H.
Right arrow Articles by Norli, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oftebro, H.
Right arrow Articles by Norli, H. R.

Journal of Clinical Endocrinology & Metabolism, Vol 78, 973-977, Copyright © 1994 by Endocrine Society


ARTICLES

Establishing a ketoconazole suppression test for verifying testosterone administration in the doping control of athletes

H Oftebro, J Jensen, P Mowinckel and HR Norli
Hormone Laboratory, Aker Hospital, Oslo, Norway.

The ratio of urinary testosterone (u-T) to epitestosterone (T/EpiT) is used to disclose testosterone (T) administration in the doping control of sports, and a ratio greater than 6 constitutes an offence. Nevertheless, the possibility of biological outliers must not be discounted, and the use of ketoconazole has been suggested for a dynamic test to distinguish between such athletes and those using T. In this investigation, ketoconazole was administrated to three groups of T- pretreated and two groups of untreated healthy male subjects. The subjects in one of the pretreated groups were patients with mild hypogonadism. One untreated group consisted of athletes that had been tested three times with high urinary T/EpiT levels. The effects of ketoconazole administration on serum T (s-T) level and urinary T/EpiT ratio were monitored every 2 h for an 8-h period and clearly separated T-pretreated and untreated subjects into two clusters (P < 0.0001). The T/EpiT ratio increased and the s-T level remained unchanged in pretreated individuals during the ketoconazole test, whereas T/EpiT decreased by 60% and s-T by almost 90% in untreated subjects. The statistical power of the test increased by using several time points and combining the urinary T/EpiT with the s-T data. In conclusion, the ketoconazole test is suitable as a supportive dynamic test for the urinary T/EpiT ratio measurements in the doping control of athletes.


This article has been cited by other articles:


Home page
Br. J. Sports. Med.Home page
C Saudan, N Baume, N Robinson, L Avois, P Mangin, and M Saugy
Testosterone and doping control
Br. J. Sports Med., July 1, 2006; 40(suppl_1): i21 - i24.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. L. Adams, E. R. Meyer, and T. J. Cicero
Imidazoles Suppress Rat Testosterone Secretion and Testicular Interstitial Fluid Formation In Vivo
Biol Reprod, August 1, 1998; 59(2): 248 - 254.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
D. H. Catlin, C. K. Hatton, and S. H. Starcevic
Issues in detecting abuse of xenobiotic anabolic steroids and testosterone by analysis of athletes' urine
Clin. Chem., July 1, 1997; 43(7): 1280 - 1288.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society